GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sipai Health Technology Co Ltd (HKSE:00314) » Definitions » Change In Payables And Accrued Expense

Sipai Health Technology Co (HKSE:00314) Change In Payables And Accrued Expense : HK$0 Mil (TTM As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Sipai Health Technology Co Change In Payables And Accrued Expense?

Sipai Health Technology Co's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2023 was HK$0 Mil. It means Sipai Health Technology Co's Accounts Payable & Accrued Expense stayed the same from Jun. 2023 to Dec. 2023 .

Sipai Health Technology Co's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was HK$0 Mil. It means Sipai Health Technology Co's Accounts Payable & Accrued Expense stayed the same from Dec. 2022 to Dec. 2023 .


Sipai Health Technology Co Change In Payables And Accrued Expense Historical Data

The historical data trend for Sipai Health Technology Co's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sipai Health Technology Co Change In Payables And Accrued Expense Chart

Sipai Health Technology Co Annual Data
Trend Dec21 Dec22 Dec23
Change In Payables And Accrued Expense
- - -

Sipai Health Technology Co Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Change In Payables And Accrued Expense - - - - -

Sipai Health Technology Co Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sipai Health Technology Co Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Sipai Health Technology Co's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Sipai Health Technology Co (HKSE:00314) Business Description

Traded in Other Exchanges
Address
No. 1888, Caoyang Road, 7/F, Building 3, Xingguangyao Plaza, Putuo District, Shanghai, CHN
Sipai Health Technology Co Ltd is a medical technology and health management company in China. It has three reportable operating segments: Specialty Pharmacy Business - operation and distribution of specialty pharmacy stores and pharmaceutical products; Physician Research Assistance Business - offering pharmaceutical companies and other clinical trial institutions site management organization services; Health Insurance Services Business - rendering insurance brokerage services to insurance companies. The company generates key revenue from Specialty Pharmacy Business. Almost all of the company's revenues were derived from operations in the PRC.
Executives
Chang Jimmy Ching-hsin 2201 Interest of corporation controlled by you
Jeneration Group Limited 2201 Interest of corporation controlled by you
Leung Catherine Ho Yan 2202 Interest of your spouse
Purple Panther 2201 Interest of corporation controlled by you
Ma Xuguang 2501 Other
Li Ji 2501 Other
Wise Approach Investments Limited 2101 Beneficial owner
Ark Trust (hong Kong) Limited 2301 Trustee
Jpmorgan Chase & Co. 2502 Approved lending agent
Lucky Seven Healthcare Co., Ltd. 2101 Beneficial owner
Simul International Holdings Limited 2201 Interest of corporation controlled by you
Oriental Power Holdings Limited
Nasturtium Investment Limited
Tencent Mobility Limited
Tencent Holdings Limited

Sipai Health Technology Co (HKSE:00314) Headlines

No Headlines